Celldex Therapeutics reported $-78.68M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
AbbVie USD 7.61B 2.04B Jun/2026
Agenus USD 39.21M 49.82M Mar/2026
Amgen USD 2.08B 570M Mar/2026
Bristol-Myers Squibb USD 4.99B 1.75B Jun/2026
Celldex Therapeutics USD -78.68M 2.63M Mar/2026
Glaxosmithkline GBP 2.14B 312M Mar/2026
Nektar Therapeutics USD -43.09M 8.39M Mar/2026
Pfizer USD -653M 5.84B Jun/2026
Rigel Pharmaceuticals USD -1.03M 7.22M Jun/2024
Roche Holding CHF 11.17B 6.38B Jun/2026